JCR Pharmaceuticals Co., Ltd. provided earnings guidance for the second quarter and year ending March 31, 2020. For the second quarter ending September 30, 2020, the company expects net sales of JPY 14,400 million, operating income of JPY 14,400 million, profit attributable to owners of parent of JPY 2,900 million and net income per share of JPY 94.07. For the full year ending March 31, 2021, the company expects net sales of JPY 27,200 million, operating income of JPY 6,000 million, profit attributable to owners of parent of JPY 4,800 million and net income per share of JPY 155.70.